Viewing Gene With Clinical Trials Data


Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/

Symbol: C9orf72
Name: C9orf72-SMCR8 complex subunit
Location: 09p21.2
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product

Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT01925196 Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation View
NCT06467175 The Benefits of Long-read High-throughput Genomic Sequencing for the Causal Diagnosis of Cerebellar Ataxias View
NCT06083584 Development of Targeted RNA-Seq for Amyotrophic Lateral Sclerosis Diagnosis View
NCT03293069 Conservative Iron Chelation as a Disease-modifying Strategy in Amyotrophic Lateral Sclerosis View
NCT05053035 A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS View
NCT01459302 Genetic Study of Familial and Sporadic ALSMotor Neuron Disease Miyoshi Myopathy and Other Neuromuscular Disorders View
NCT04931862 Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis ALS or Frontotemporal Dementia FTD View
NCT05358431 Stratification of Presymptomatic Amyotrophic Lateral Sclerosis the Development of Novel Imaging Biomarkers View
NCT04060082 Voices Of Individuals Challenges and Experiences Of bvFTD View
NCT02372773 Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects View
NCT04220021 Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALSFTD View
NCT03573466 Presymptomatic Neuromuscular Junction Defects and Compensatory Mechanisms in ALS View
NCT02686268 Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS View
NCT05747937 Longitudinal Assessment of Autonomic and Sensory Nervous System in ALS View
NCT04288856 Study to Assess the Safety Tolerability Pharmacokinetics and Effect on Disease Progression of BIIB078 Administered to Previously Treated Adults C9ORF72-Associated Amyotrophic Lateral Sclerosis ALS View
NCT03626012 A Study to Assess the Safety Tolerability and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis View
NCT03865420 Amyotrophic Lateral Sclerosis ALS Families Project View
NCT03987295 A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia FTD Patients INFRONT-2 View
NCT05683860 Open-label Extension OLE Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis ALS andor Frontotemporal Dementia FTD View
NCT04516499 Neurofilament Surveillance Project NSP View
NCT04639622 GENetic Fronto Temporal Dementia Initiative in Lille View
NCT05852405 Clinical Characteristics Natural History Health Care Measures and Genetic Screening in Patients With ALS View
NCT04819555 Frequency of SOD1 and C9orf72 Gene Mutations in French ALS View
NCT04993755 A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALSFTD View
NCT05163886 Study of Safety Tolerability and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral Sclerosis View
NCT05189106 Neurodegenerative Alzheimers Disease and Amyotrophic Lateral Sclerosis NADALS Basket Trial View
NCT05483322 An Open-Label Expanded Access Protocol of LAM-002A in C9ORF72-Associated Frontotemporal Dementia FTD View
NCT05779813 Genetic Frontotemporal Dementia Initiative for Neurodevelopment View
NCT00317616 The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis Pre-fALS Study View
NCT02590276 Predict to Prevent Frontotemporal Lobar Degeneration FDT and Amyotrophic Lateral Sclerosis ALS View